PEQRX
Price
$37.08
Change
+$0.22 (+0.60%)
Updated
Jul 3 closing price
Net Assets
39.89B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PEQRX vs VIVAX

Header iconPEQRX vs VIVAX Comparison
Open Charts PEQRX vs VIVAXBanner chart's image
Putnam Large Cap Value R
Price$37.08
Change+$0.22 (+0.60%)
VolumeN/A
Net Assets39.89B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PEQRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PEQRX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. PEQRX (39.9B). VIVAX pays higher dividends than PEQRX: VIVAX (2.06) vs PEQRX (0.68). PEQRX was incepted earlier than VIVAX: PEQRX (22 years) vs VIVAX (33 years). PEQRX (1.13) is less costly to investors than VIVAX (0.17). PEQRX is a more actively managed with annual turnover of: 16.00 vs. VIVAX (9.00). PEQRX has a lower initial minimum investment than VIVAX: PEQRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. PEQRX (7.85). VIVAX return over 5 years is better than : 80.14 vs. PEQRX (69.46).
PEQRXVIVAXPEQRX / VIVAX
Total Expense Ratio1.130.17665%
Annual Report Gross Expense Ratio1.130.17665%
Fund Existence22 years33 years-
Gain YTD9.1056.209147%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets39.9B189B21%
Annual Yield % from dividends0.682.0633%
Returns for 1 year7.8512.0465%
Returns for 3 years36.5435.16104%
Returns for 5 years69.4680.1487%
Returns for 10 years91.18115.7479%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.